Skip to content

Active ingredient

Entecavir

31 finished FDA listings contain Entecavir as their only active ingredient.

FDA NDC Directory

Ingredient names as written by FDA
ENTECAVIR, ENTECAVIR ANHYDROUS
Dosage forms
Solution, Tablet, Tablet, Film Coated
Routes
Oral
Manufacturers / labelers
17
Strengths listed
.05 mg/ml · .5 mg/1 · 1 mg/1
Brand names in FDA listings
Baraclude, Entecavir

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 306266

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 021797BRISTOL MYERS SQUIBB2005-03-292
NDA 021798BRISTOL MYERS SQUIBB2005-03-291
ANDA 205740HETERO LABS LTD V2015-08-212
ANDA 206217AUROBINDO PHARMA2015-08-263
ANDA 206652AMNEAL PHARMS2015-11-123
ANDA 206872CIPLA2016-12-064
ANDA 206745ZYDUS PHARMS2017-06-234
ANDA 208782PRINSTON INC2017-10-102
ANDA 212126BRIGHTGENE2019-09-252
ANDA 212201YAOPHARMA CO LTD2019-11-042
ANDA 208195YUNG SHIN PHARM2021-11-102
ANDA 216857CONBA USA2024-12-234

Official labeling on DailyMed

Showing the 12 most recent of 16 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.